IT8922199A0 - Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche - Google Patents

Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche

Info

Publication number
IT8922199A0
IT8922199A0 IT22199A IT2219989A IT8922199A0 IT 8922199 A0 IT8922199 A0 IT 8922199A0 IT 22199 A IT22199 A IT 22199A IT 2219989 A IT2219989 A IT 2219989A IT 8922199 A0 IT8922199 A0 IT 8922199A0
Authority
IT
Italy
Prior art keywords
anemic
cyclodextrins
complexes
indicated
preparation
Prior art date
Application number
IT22199A
Other languages
English (en)
Other versions
IT1237509B (it
IT8922199A1 (it
Inventor
Laura Puricelli
Original Assignee
Magis Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magis Farmaceutici filed Critical Magis Farmaceutici
Priority to IT02219989A priority Critical patent/IT1237509B/it
Publication of IT8922199A0 publication Critical patent/IT8922199A0/it
Priority to EP90120676A priority patent/EP0427078A1/en
Publication of IT8922199A1 publication Critical patent/IT8922199A1/it
Application granted granted Critical
Publication of IT1237509B publication Critical patent/IT1237509B/it

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT02219989A 1989-10-31 1989-10-31 Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche IT1237509B (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT02219989A IT1237509B (it) 1989-10-31 1989-10-31 Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche
EP90120676A EP0427078A1 (en) 1989-10-31 1990-10-29 Folinic acid-cyclodextrin inclusion compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02219989A IT1237509B (it) 1989-10-31 1989-10-31 Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche

Publications (3)

Publication Number Publication Date
IT8922199A0 true IT8922199A0 (it) 1989-10-31
IT8922199A1 IT8922199A1 (it) 1991-05-01
IT1237509B IT1237509B (it) 1993-06-08

Family

ID=11192944

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02219989A IT1237509B (it) 1989-10-31 1989-10-31 Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche

Country Status (2)

Country Link
EP (1) EP0427078A1 (it)
IT (1) IT1237509B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684644A5 (de) * 1992-07-13 1994-11-15 Eprova Ag 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
ES2373867T3 (es) 2007-03-02 2012-02-09 The University Of Wollongong Composiciones y procedimientos para el suministro de agentes anticancerosos.
CN102000345A (zh) * 2010-11-16 2011-04-06 广西大学 包合态的叶酸/β-环糊精组合物及其制备方法
CN107751576A (zh) * 2017-11-13 2018-03-06 厦门大学 一种复合维生素液及其制备方法
GR1009589B (el) * 2018-04-05 2019-09-11 Ιουλια Κλεωνος Τσετη Φαρμακευτικο σκευασμα για την αντιμετωπιση της αναιμιας, σε καταλληλο περιεκτη, που διατηρει στεγανα διαχωρισμενα μεταξυ τους τα δραστικα συστατικα: συμπλοκο του τρισθενους σιδηρου με ν-ακετυλο-l-ασπαρτικη καζεϊνη και πενταϋδρικο φυλλινικο ασβεστιο
GR1009597B (el) * 2018-04-16 2019-09-16 Ιουλια Κλεωνος Τσετη Φαρμακευτικο σκευασμα για την ενισχυση των επιπεδων σιδηρου στο αιμα, που περιεχει πολυμαλτοζικο σιδηρο (ιιι) και μια δραστικη ουσια επιλεγμενη απο πενταϋδρικο φυλλινικο ασβεστιο, βιταμινη c ή συνδυασμο των δυο, που ενισχυει την απορροφηση σιδηρου
CN112089848A (zh) * 2020-10-27 2020-12-18 浙江诺得药业有限公司 叶酸的环糊精包合物及其制备方法
CN112618500B (zh) * 2020-12-24 2022-12-09 广州汉光药业股份有限公司 叶酸制剂及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine

Also Published As

Publication number Publication date
IT1237509B (it) 1993-06-08
EP0427078A1 (en) 1991-05-15
IT8922199A1 (it) 1991-05-01

Similar Documents

Publication Publication Date Title
IT1201149B (it) Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1215291B (it) Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.
IT8847556A0 (it) Derivati peptidici, loro preparazione e loro impiego come medicamenti
IT8820074A0 (it) Complessi di platino (ii), loro preparazione e impiego come antitumorali.
OA09458A (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof.
IT8821134A0 (it) Frazioni oligomeriche procianidoliche, loro procedimentodi preparazione e composizioni farmaceutiche che le contengono.
IT8547852A0 (it) Ciclosporine,processi per la loro preparazione,uso farmaceutico delle stesse e composizioni farmaceutiche che le contengono
IT8219947A0 (it) Complessi platino-diamminici eprocedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi.
IT9019829A0 (it) Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche
IT1229562B (it) Composizioni farmaceutiche antivirali ed immunostimolanti e procedimento per la loro preparazione.
IT8921962A0 (it) Complessi di inclusione con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono
IT1219542B (it) Derivati pepticidi,loro preparazione e loro impiego come medicamenti
IT8922199A0 (it) Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche
IT9019793A0 (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
IT1150759B (it) Complessi organometallici di n-cicloesil-piperazino-acetammidi o propionammidi, loro preparazione e impiego come farmaci antiulcera-antisecretivi-tamponanti
IT1237783B (it) Derivati di ferro-albumina biodisponibile, loro procedimento di preparazione e relative composizioni farmaceutiche.
IT8847912A0 (it) Derivati di forskolina, loro procedimento ed intermedi di preparazione, loro applicazione in qualita'di medicamenti e composizioni farmaceutiche che li contengono
AU632313B2 (en) New platinum complexes, their preparation and pharmaceutical compositions which contain them
IT8722631A0 (it) Derivati proteici del ferro altamente biodisponibile e tollerabili, loro preparazione e composizioni farmaceutiche che licontengono.
IT8847578A0 (it) Derivati della pilocarpina, loro preparazione e loro impiego come medicamenti
ITMI912938A0 (it) Complessi del platino(ii)anti-tumorali e procedimento per la loro preparazione
IT8922503A0 (it) Composti ottenuti per complessazione della pentossifillina con ciclodeciclodestrine, loro preparazione e relative composizioni farmaceutiche
IT8720179A0 (it) 2-sulfinil-acetil-1,3-tiazolidine, loro preparazione e composizioni farmaceutiche.
IT8921929A0 (it) Complessi del 4-idrossi-2-metil-n--2-piridinil-2-h,2-benzotiazina-3- carbossiammide-1,1-diossido con cilodestrine, aventi azione anti- infiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche

Legal Events

Date Code Title Description
0001 Granted